Regenerative Medicine for Orthopedic Pain in Palm Beach

What orthopedic regenerative medicine means

Orthopedic regenerative medicine is a broad term for treatments that aim to support the body’s healing response, reduce pain, improve function, or help a patient delay a more invasive procedure when appropriate. At Wellington Orthopedic Institute, this conversation may include platelet-rich plasma (PRP), hyaluronic acid (HA) injections, ultrasound-guided injections, cartilage restoration, selected biologic surgical support, and stem cell or MSC consultations.

The key phrase is “when appropriate.” Regenerative medicine should not be sold as a miracle or used as a replacement for a real orthopedic diagnosis. Pain can come from cartilage loss, tendon injury, ligament instability, nerve irritation, bursitis, inflammatory disease, fracture, or advanced joint collapse. The right treatment depends on the structure involved and the stage of damage.

Dr. Michael Mikolajczak, DO takes a conservative-first approach. That does not mean avoiding surgery at all costs. It means surgery should be the last resort after appropriate non-surgical options have been evaluated. If your joint damage is mild or moderate, regenerative medicine may be part of a plan. If your joint is severely damaged, surgery may be the more predictable and honest recommendation.

Why Palm Beach patients look for regenerative options

Many active adults want to keep playing tennis, golf, pickleball, running, working, traveling, and living without months of downtime. They may not be ready for joint replacement, or they may have been told they are “too young” for surgery but still have daily pain. Others have tried cortisone injections that helped for a short period, then wore off. Some want a second opinion before agreeing to an operation.

Regenerative medicine fits into that decision point. It may offer a lower-downtime option for selected problems, but it also requires patience. PRP and HA do not typically provide instant relief the way some anti-inflammatory injections can. When improvement occurs, it is often gradual over weeks to months. That is why Dr. Mikolajczak frames these treatments as part of a complete orthopedic plan, not as a one-shot shortcut.

Regenerative and injection options offered

PRP — platelet-rich plasma

PRP starts with a small sample of your own blood. The sample is processed to concentrate platelets, then injected into the target area. Platelets contain growth factors and signaling proteins involved in the body’s natural healing response. PRP may be considered for mild to moderate knee osteoarthritis, selected shoulder and rotator cuff problems, elbow tendon pain, hip or tendon conditions, and other soft-tissue problems after evaluation.

Published research covering 18 randomized controlled trials and 1,995 patients found PRP exceeded the minimum clinically important difference for knee osteoarthritis pain at 1, 3, 6, and 12 months. Clinical studies in rotator cuff repair have associated PRP with approximately 38% lower retear rates versus control. These findings are encouraging, but individual results vary and not every diagnosis has the same level of evidence.

HA / viscosupplementation

Hyaluronic acid is a naturally occurring lubricant in healthy joints. In knee osteoarthritis, the joint fluid can become thinner and less protective. HA injections are designed to improve lubrication and reduce friction inside the joint. This option is best known for mild to moderate knee osteoarthritis and for patients who want to delay surgery.

Published clinical studies support symptom benefits up to 6 months in appropriate candidates, and published data suggests HA may delay total knee replacement by approximately 4 years for some patients. A major practical advantage is insurance: HA is covered by many insurance plans for knee osteoarthritis when medical criteria are met, unlike PRP, which is commonly cash pay.

Stem cell / MSC consultation

Mesenchymal stem cell, or MSC, therapy is an advanced biologic topic in orthopedics. Early research is promising for areas such as cartilage support, bone healing, and tendon repair, but “promising” does not mean proven for every patient or approved for every condition. No stem cell or MSC therapy is currently FDA-approved for orthopedic joint conditions.

Dr. Mikolajczak offers consultation because patients deserve a transparent explanation of what is known, what is developing, and what is not approved. We do not oversell it. We explain it. A stem cell or MSC discussion requires imaging review, medical history review, labs when appropriate, and a candid conversation about cost, evidence, and alternatives. These services are cash pay and require physician evaluation before any recommendation.

Cartilage restoration and biologic surgical support

Some regenerative strategies are not simple office injections. Cartilage restoration procedures may be considered for focal cartilage defects in patients whose joint is otherwise reasonably preserved. Bone grafting, biologic scaffolds, and growth factor applications may be used in selected surgical contexts such as fracture repair, fusion, or joint reconstruction. These decisions depend on imaging, diagnosis, patient age, activity goals, and insurance authorization.

How it works at Wellington Orthopedic Institute

Step 1: Evaluation. Dr. Mike reviews your imaging, history, prior treatments, medical conditions, and goals. If you do not have appropriate imaging, he may recommend it before deciding on an injection. The goal is to identify the pain generator and the stage of damage.

Step 2: Individualized protocol. Not every patient needs the same injection. A knee arthritis patient considering HA is different from a tennis elbow patient considering PRP. A patient with severe bone-on-bone arthritis may be better served by surgical consultation. Dr. Mikolajczak explains the reasoning instead of pushing a standard package.

Step 3: Ultrasound guidance. Every injection is ultrasound-guided for precision. Ultrasound allows real-time visualization of the target area, helping the medication or biologic preparation reach the intended joint, tendon, bursa, or soft-tissue structure.

Step 4: Recovery plan. Injections work best when paired with the right aftercare. Depending on your diagnosis, that may include physical therapy, strengthening, temporary activity modification, bracing, weight-loss support, or follow-up imaging. The appointment is only one part of the plan.

Regenerative medicine vs surgery: how Dr. Mike thinks about the decision

A good regenerative candidate often has mild to moderate joint damage, a focal tendon or cartilage problem, preserved joint space, and enough time to allow gradual improvement. A better surgical candidate may have severe bone-on-bone arthritis, major structural damage, mechanical instability, or pain and disability that have not responded to appropriate conservative treatment.

Age alone does not determine the answer. A younger active patient may still need surgery if the injury is structurally severe. An older patient may still be a regenerative candidate if the joint is not too damaged and the goal is to delay surgery safely. The real decision comes from matching the diagnosis, imaging, activity goals, recovery timeline, and insurance or cash-pay considerations.

Insurance and cash-pay transparency

Insurance coverage varies by diagnosis and treatment. HA injections are covered by many insurance plans for knee osteoarthritis when criteria are met. PRP is typically considered experimental by many carriers and is commonly cash pay. Stem cell or MSC consultations and procedures are cash pay, and Dr. Mikolajczak discusses pricing only after determining whether the option is medically appropriate to consider.

Wellington Orthopedic Institute does not believe patients should be surprised by the difference between an insurance-covered service and a cash-pay biologic option. The office can help you understand the practical next steps before you proceed.

Important regenerative medicine disclaimers

Regenerative treatments are medical procedures and are not appropriate for every patient. PRP is not FDA-approved for all orthopedic indications. No stem cell or MSC therapy is currently FDA-approved for orthopedic joint conditions. HA coverage depends on diagnosis, insurance plan, and medical necessity. This page is informational only and does not constitute medical advice. Individual results vary, and no outcome can be guaranteed.